ESMO Virtual Plenary with AACR Expert Commentary: May 2024

Welcome and introduction, Scientific background and context
Giampaolo Bianchini, IRCCS Ospedale San Raffaele, Milan, Italy

Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
Huiping Li, Peking University Cancer Hospital and Institute, Beijing, China 

Critical analysis and perspectives
Evandro de Azambuja, Institute Jules Bordet, Brussels, Belgium

Discussion and Q&A (i)
Faculty and online audience

Virtual Plenary Expert Insights: Webcast of 9 May presentations, Discussion and Q&A (ii)
Faculty and online audience

Chair: Rebecca Dent, NCCS – National Cancer Centre Singapore, Singapore

Huiping Li, Peking University Cancer Hospital and Institute,  Beijing, China 

Evandro de Azambuja, Institute Jules Bordet, Brussels, Belgium

Smruti Koppikar, Bombay Hospital and Medical Research Center, Mumbai, India

Mastura MD Yusof, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia

Welcome and introduction, Scientific background and context
Stefan Bielack, Klinikum Stuttgart - Olgahospital / Frauenklinik, Stuttgart, Germany

A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse
Jean-Yves Blay, Centre Léon Bérard, Lyon, France

Critical analysis and perspectives
Hans Gelderblom, LUMC-Leiden University Medical Center, Leiden, the Netherlands

AACR Expert Commentary
Michael Heinrich, OHSU Knight Cancer Institute, Portland, OR, USA

Discussion and Q&A (i)
Faculty and online audience

Virtual Plenary Expert Insights: Webcast of 9 May presentations, Discussion and Q&A (ii)
Faculty and online audience

Chair: Herbert Loong, The Chinese University of Hong Kong - Prince of Wales Hospital, Hong Kong SAR, China

Jean-Yves Blay, Centre Léon Bérard, Lyon, France

Hans Gelderblom, LUMC-Leiden University Medical Center, Leiden, the Netherlands

Tom Wei-Wu Chen, NTU - National Taiwan University - College of Medicine, Taipei City, Taiwan

Myo Myint Maw, YGH – Yangon General Hospital, Yangon, Myanmar

Virote Sriuranpong, King Chulalongkorn Memorial Hospital - Thai Red Cross Society, Bangkok, Thailand